SOX2 and testicular germ cell tumor: Collectively, the observed shift in seminomatous cells toward a dedifferentiated phenotype, marked by reduced SOX17 and variable SOX2 upregulation, may contribute to increased malignancy or chemoresistance in TGCT patients [19].